These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 32142862)

  • 41. Initial Molecular Mechanisms of the Pathogenesis of Parkinson's Disease in a Mouse Neurotoxic Model of the Earliest Preclinical Stage of This Disease.
    Kolacheva A; Pavlova E; Bannikova A; Bogdanov V; Ugrumov M
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38279354
    [TBL] [Abstract][Full Text] [Related]  

  • 42. ser31 Tyrosine hydroxylase phosphorylation parallels differences in dopamine recovery in nigrostriatal pathway following 6-OHDA lesion.
    Salvatore MF
    J Neurochem; 2014 May; 129(3):548-58. PubMed ID: 24410633
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of the effect of rotenone and 1‑methyl‑4‑phenyl‑1,2,3,6‑tetrahydropyridine on inducing chronic Parkinson's disease in mouse models.
    Zhang J; Sun B; Yang J; Chen Z; Li Z; Zhang N; Li H; Shen L
    Mol Med Rep; 2022 Mar; 25(3):. PubMed ID: 35039876
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Neuroprotective effect of the chemical chaperone, trehalose in a chronic MPTP-induced Parkinson's disease mouse model.
    Sarkar S; Chigurupati S; Raymick J; Mann D; Bowyer JF; Schmitt T; Beger RD; Hanig JP; Schmued LC; Paule MG
    Neurotoxicology; 2014 Sep; 44():250-62. PubMed ID: 25064079
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Dose-related biphasic effect of the Parkinson's disease neurotoxin MPTP, on the spread, accumulation, and toxicity of α-synuclein.
    Merghani MM; Ardah MT; Al Shamsi M; Kitada T; Haque ME
    Neurotoxicology; 2021 May; 84():41-52. PubMed ID: 33549656
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Protection of dopaminergic neurons with a novel astrocyte modulating agent (R)-(-)-2-propyloctanoic acid (ONO-2506) in an MPTP-mouse model of Parkinson's disease.
    Kato H; Araki T; Imai Y; Takahashi A; Itoyama Y
    J Neurol Sci; 2003 Apr; 208(1-2):9-15. PubMed ID: 12639719
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Isotopic reinforcement of essential polyunsaturated fatty acids diminishes nigrostriatal degeneration in a mouse model of Parkinson's disease.
    Shchepinov MS; Chou VP; Pollock E; Langston JW; Cantor CR; Molinari RJ; Manning-Boğ AB
    Toxicol Lett; 2011 Nov; 207(2):97-103. PubMed ID: 21906664
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunohistochemical evaluation of the neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on dopaminergic nigrostriatal neurons of young adult mice using dopamine and tyrosine hydroxylase antibodies.
    Mori S; Fujitake J; Kuno S; Sano Y
    Neurosci Lett; 1988 Jul; 90(1-2):57-62. PubMed ID: 2901058
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Whether the Subacute MPTP-Treated Mouse is as Suitable as a Classic Model of Parkinsonism.
    Qi Y; Zhang Z; Li Y; Zhao G; Huang J; Zhang Y; Xue J; Tang X
    Neuromolecular Med; 2023 Sep; 25(3):360-374. PubMed ID: 36913134
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Estrogen Increases Striatal GDNF Immunoreactivity with no Effect on Striatal FGF-2 Immunoreactivity of MPTP-Treated Mice.
    Tripanichkul W; Jaroensuppaperch EO
    J Med Assoc Thai; 2015 Oct; 98 Suppl 9():S16-22. PubMed ID: 26817205
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neuroprotective effect of silymarin in a MPTP mouse model of Parkinson's disease.
    Pérez-H J; Carrillo-S C; García E; Ruiz-Mar G; Pérez-Tamayo R; Chavarría A
    Toxicology; 2014 May; 319():38-43. PubMed ID: 24607817
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Modeling of the Progressive Degradation of the Nigrostriatal Dopaminergic System in Mice to Study the Mechanisms of Neurodegeneration and Neuroplasticity in Parkinson's Disease.
    Kolacheva A; Bannikova A; Pavlova E; Bogdanov V; Ugrumov M
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614126
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Broad neuroprotective profile of nicotinamide in different mouse models of MPTP-induced parkinsonism.
    Anderson DW; Bradbury KA; Schneider JS
    Eur J Neurosci; 2008 Aug; 28(3):610-7. PubMed ID: 18702732
    [TBL] [Abstract][Full Text] [Related]  

  • 54. EGb761 protects against nigrostriatal dopaminergic neurotoxicity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice: role of oxidative stress.
    Rojas P; Serrano-García N; Mares-Sámano JJ; Medina-Campos ON; Pedraza-Chaverri J; Ogren SO
    Eur J Neurosci; 2008 Jul; 28(1):41-50. PubMed ID: 18662333
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A beam-walking apparatus to assess behavioural impairments in MPTP-treated mice: pharmacological validation with R-(-)-deprenyl.
    Quinn LP; Perren MJ; Brackenborough KT; Woodhams PL; Vidgeon-Hart M; Chapman H; Pangalos MN; Upton N; Virley DJ
    J Neurosci Methods; 2007 Aug; 164(1):43-9. PubMed ID: 17498809
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MPTP-treated young mice but not aging mice show partial recovery of the nigrostriatal dopaminergic system by stereotaxic injection of acidic fibroblast growth factor (aFGF).
    Date I; Notter MF; Felten SY; Felten DL
    Brain Res; 1990 Aug; 526(1):156-60. PubMed ID: 1706636
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neuroprotective effects of genistein on dopaminergic neurons in the mice model of Parkinson's disease.
    Liu LX; Chen WF; Xie JX; Wong MS
    Neurosci Res; 2008 Feb; 60(2):156-61. PubMed ID: 18054104
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neuroprotective effects of stemazole in the MPTP-induced acute model of Parkinson's disease: Involvement of the dopamine system.
    Guo Z; Xu S; Du N; Liu J; Huang Y; Han M
    Neurosci Lett; 2016 Mar; 616():152-9. PubMed ID: 26827716
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hippocampal damage and white matter lesions contribute to cognitive impairment in MPTP-lesioned mice with chronic cerebral hypoperfusion.
    Gao Y; Tang H; Nie K; Zhu R; Gao L; Feng S; Wang L; Zhao J; Huang Z; Zhang Y; Wang L
    Behav Brain Res; 2019 Aug; 368():111885. PubMed ID: 30959125
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Admixing of MPTP-Resistant and Susceptible Mice Strains Augments Nigrostriatal Neuronal Correlates to Resist MPTP-Induced Neurodegeneration.
    Vidyadhara DJ; Yarreiphang H; Raju TR; Alladi PA
    Mol Neurobiol; 2017 Oct; 54(8):6148-6162. PubMed ID: 27704331
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.